Controlled delivery of the heparan sulfate/FGF-2 complex by a polyelectrolyte scaffold promotes maximal hMSC proliferation and differentiation

Journal of Cellular Biochemistry

Volumn 110, Issue 4, 2010, Pages 903-909

  Calarco, Anna ^a   Petillo, Orsolina ^a   Bosetti, Michela ^b   Torpedine, Angela ^a   Cannas, Mario ^b   Perrone, Lorena ^c   Galderisi, Umberto ^d   Melone, Mariarosa A B ^d   Peluso, Gianfranco ^a  

^a INSTITUTE OF PROTEIN BIOCHEMISTRY   (Italy)

^b UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^c CNRS   (France)

^d SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Controlled delivery; FGF 2; Mesenchymal stem cells; Polyelectrolyte polymer

Indexed keywords

HEPARAN SULFATE; POLYELECTROLYTE; RECOMBINANT FIBROBLAST GROWTH FACTOR; RECOMBINANT FIBROBLAST GROWTH FACTOR 2; UNCLASSIFIED DRUG; CATION; ELECTROLYTE; FIBROBLAST GROWTH FACTOR 2; POLYMER; PRIMER DNA;

ARTICLE; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; FIBROBLAST; HUMAN; HUMAN CELL; MESENCHYMAL STEM CELL; PRIORITY JOURNAL; CELL CULTURE; CELL LINEAGE; CHEMISTRY; DRUG EFFECTS; MESENCHYMAL STROMA CELL; NUCLEOTIDE SEQUENCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

BASE SEQUENCE; CATIONS; CELL DIFFERENTIATION; CELL LINEAGE; CELL PROLIFERATION; CELLS, CULTURED; DNA PRIMERS; ELECTROLYTES; FIBROBLAST GROWTH FACTOR 2; HEPARITIN SULFATE; HUMANS; MESENCHYMAL STROMAL CELLS; POLYMERS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 77954107474     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.22602     Document Type: Article

References (44)

1. Altman GH, Horan RL, Martin I, Farhadi J, Stark PR, Volloch V, Richmond JC, Vunjak-Novakovic G, Kaplan DL. 2002. Cell differentiation by mechanical stress. FASEB J 16:270-272.
2. Arakawa T, Wen J, Philo JS. 1994. Stoichiometry of heparin binding to bFGF. Arch Biochem Biophys 308:267-273.
3. Bernfield M, Gotte M, Park PW, Reizes O, Fitzgerald ML, Lincecum J, Zako M. 1999. Functions of cell surface heparan sulfate proteoglycans. Annu Rev Biochem 68:729-777.
4. Bianco P, Robey PG. 2001. Stem cells in tissue engineering. Nature 414:118-121.
5. Bush MA, Samara E, Whitehouse MJ, Yoshizawa C, Novicki DL, Pike M, Laham RJ, Simons M, Chronos NA. 2001. Pharmacokinetics and pharmacodynamics of recombinant FGF-2 in a phase I trial in coronary artery disease. J Clin Pharmacol 41:378-385.
6. Caplan AI, Bruder SP. 2001. Mesenchymal stem cells: Building blocks for molecular medicine in the 21st century. Trends Mol Med 7:259-264.
7. Chan BP, Fu S, Qin L, Lee K, Rolf CG, Chan K. 2000. Effects of basic fibroblast growth factor (bFGF) on early stages of tendon healing: A rat patellar tendon model. Acta Orthop Scand 71:513-518.
8. Chen RR, Mooney DJ. 2003. Polymeric growth factor delivery strategies for tissue engineering. Pharm Res 20:1103-1112.
9. Cristino S, Grassi F, Toneguzzi S, Piacentini A, Grigolo B, Santi S, Riccio M, Tognana E, Facchini A, Lisignoli G. 2005. Analysis of mesenchymal stem cells grown on a three-dimensional HYAFF11r-based prototype ligament scaffold. J Biomed Mater Res 73:275-283.
10. Cserjesi P, Brown D, Ligon KL, Lyons GE, Copeland NG, Gilbert DJ, Jenkins NA, Olson EN. 1995. Scleraxis: A basic helix-loop-helix protein that prefigures skeletal formation during mouse embryogenesis. Development 121:1099-1110.
11. De Rosa M, Cartenì M, Petillo O, Calarco A, Margarucci S, Rosso F, De Rosa A, Farina E, Grippo P, Peluso G. 2004. Cationic polyelectrolyte hydrogel fosters fibroblast spreading, proliferation and extracellular matrix production: Implications for tissue engineering. J Cell Physiol 198:133-143.
12. Deblois C, Cote MF, Doilon CJ. 1994. Heparin-fibroblast growth factor-fibrin complex: In vitro and in vivo applications to collagen-based materials. Biomaterials 15:665-672.
13. Denizli A. 1999. Heparin-immobilized poly(2-hydroxyethylmethacrylate)- based microspheres. J Applied Polym Sci 74:655-662.
14. Dombrowski C, Song SJ, Chuan P, Lim X, Susanto E, Sawyer AA, Woodruff MA, Hutmacher DW, Nurcombe V, Cool SM. 2009. Heparan sulfate mediates the proliferation and differentiation of rat mesenchymal stem cells. Stem Cells Dev 18:661-670.
15. Edelman ER, Mathiowitz E, Langer R, Klagsbrun M. 1991. Controlled and modulated release of basic fibroblast growth factor. Biomaterials 12:619-626.
16. Friedl A, Chang Z, Tierney A, Rapraeger AC. 1997. Differential binding of fibroblast growth factor-2 and -7 to basement membrane heparan sulfate: Comparison of normal and abnormal human tissues. Am J Pathol 150:1443-1455. (Pubitemid 27152661)
17. Hankemeier S, Keus M, Zeichen J, Jagodzinski M, Barkhausen T, Bosch U, Krettek C, Van Griensven M. 2005. Modulation of proliferation and differentiation of human bone marrow stromal cells by fibroblast growth factor 2: Potential implications for tissue engineering of tendons and ligaments. Tissue Eng 11:41-49.
18. Hile DD, Amirpour ML, Akgerman A, Pishko MV. 2000. Active growth factor delivery from poly(d,l-lactide-co-glycolide) foams prepared in supercritical CO2. J Control Release 66:177-185.
19. Jackson RA, Murali S, van Wijnen AJ, Stein GS, Nutcombe V, Cool SM. 2007. Heparan sulfate regulates the anabolic activity of MC3T3-EI preosteoblast cells by induction of Runx2. J Cell physiol 210:38-50.
20. Jacob AL, Smith C, Partanen J, Ornitz DM. 2006. Fibroblast growth factor receptor 1 signaling in the osteo-chondrogenic cell lineage regulates sequential steps of osteoblast maturation. Dev Biol 296:315-328.
21. Laham RJ, Chronos NA, Pike M, Leimbach ME, Udelson JE, Pearlman JD, Pettigrew RI, Whitehouse MJ, Yoshizawa C, Simons M. 2000. Intracoronary basic fibroblast growth factor (FGF-2) in patients with severe ischemic heart disease: results of phase I open-label dose escalation study. J Am Coll Cardiol 36:2132-2139.
22. Lalan S, Pomerantseva I, Vacanti JP. 2001. Tissue engineering and its potential impact on surgery. World J Surg 25:1458-1466.
23. Lee JH, Kosinski PA, Kemp DM. 2005. Contribution of human bone marrow stem cells to individual skeletal myotubes followed by myogenic gene activation. Exp Cell Res 307:174-182.
24. Liu LS, Thompson AY, Poser JW, Spiro RC. 1998. Hyaluronate derivatives-based materials for growth factor delivery and tissue regeneration. Proceedings of the 25th International Symposium on Controlled Release Bioactive Materials, Vol. 25. pp 996-997.
25. Long X, Olszewski M, Huang W, Kletzel M. 2005. Neural cell differentiation in vitro from adult human bone marrow mesenchymal stem cells. Stem Cells Dev 14:65-69. (Pubitemid 40328249)
26. Maccarana M, Lindahl U. 1993. Mode of interaction between platelet factor 4 and heparin. Glycobiology 3:271-277. (Pubitemid 23232161)
27. Mauney JR, Volloch V, Kaplan DL. 2005. Matrix-mediated retention of adipogenic differentiation potential by human adult bone marrow-derived mesenchymal stem cells during ex vivo expansion. Biomaterials 26:6167-6175.
28. Moreau JE, Chen J, Bramono DS, Volloch V, Chernoff H, Vunjak-Novakovic G, Richmond JC, Kaplan DL, Altman GH. 2005. Growth factor induced fibroblast differentiation from human bone marrow stromal cells in vitro. J Orthop Res 23:164-174. (Pubitemid 40045091)
29. Murchison ND, Price BA, Conner DA, Keene DR, Olson EN, Tabin CJ, Schweitzer R. 2007. Regulation of tendon differentiation by scleraxis distinguishes force-transmitting tendons from muscle-anchoring tendons. Development 134:2697-2708.
30. Neubauer M, Fischbach C, Bauer-Kreisel P, Lieb E, Hacker M, Tessmar J, Schulz MB, Goepferich A, Blunk T. 2004. Basic fibroblast growth factor enhances PPAR-gamma ligand-induced adipogenesis of mesenchymal stem cells. FEBS Lett 577:277-283.
31. Nilasaroya A, Poole-Warren LA, Whitelock JM, Jo Martens P. 2008. Structural and functional characterisation of poly(vinyl alcohol) and heparin hydrogels. Biomaterials 29:4658-4664.
32. Otto WR, Rao J. 2004. Tomorrow's skeleton staff: Mesenchymal stem cells and the repair of bone and cartilage. Cell Prolif 37:97-110.
33. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR. 1999. Multilineage potential of adult human mesechymal stem cells. Science 84:143-147.
34. Schuksz M, Fuster MM, Brown JR, Crawford BE, Ditto DP, Lawrence R, Glass CA, Wang L, Tor Y, Esko JD. 2008. Surefen, a small molecule antagonist of heparin sulfate. Proc Natl Acad Sci 105:13075-13080.
35. Solchaga LA, Penick K, Porter JD, Goldberg VM, Caplan AI, Welter JF. 2005. FGF-2 enhances the mitotic and chondrogenic potentials of human adult bone marrow-derived mesenchymal stem cells. J Cell Physiol 203:398-409.
36. Tabata Y, Yamada K, Miyamoto S, Nagata I, Kikuchi H, Aoyama I, Tamura M, Ikada Y. 1998. Bone regeneration by basic fibroblast growth factor complexed with biodegradable hydrogels. Biomaterials 19:807-815. (Pubitemid 28278241)
37. Thompson LD, Pantoliano MW, Springer BA. 1994. Energetic characterization of the basic fibroblast growth factor-heparin interaction: Identification of the heparin binding domain. Biochemistry 33:3831-3840.
38. Tsutsumi S, Shimazu A, Miyazaki K, Pan H, Koike C, Yoshida E, Takagishi K, Kato Y. 2001. Retention of multilineage differentiation potential of mesenchymal cells during proliferation in response to FGF. Biochem Biophys Res Commun 288:413-419.
39. Turnbull J, Powell A, Guimond S. 2001. Heparan sulfate: Decoding a dynamic multifunctional cell regulator. Trends Cell Biol 11:75-82.
40. Watanabe K. 2004. Assessment of gene expression during osteoblast induction of human mesenchymal stem cells. Kokubyo Gakkai Zasshi 71:11-17.
41. Winer J, Jung CK, Shackel I, Williams PM. 1999. Development and validation of real-time quantitative reverse transcriptasepolymerase chain reaction for monitoring gene expression in cardiac myocytes in vitro. Anal Biochem 270:41e9.
42. Woei NgK, Speicher T, Dombrowski C, Helledie T, Haupt LM, Nurcombe V, Cool SM. 2007. Osteogenic differentiation of murine embryonic stem cells is mediated by fibroblast growth factor receptors. Stem Cells Dev 16:305-318.
43. Yamada K, Tabata Y, Yamamoto K, Miyamoto S, Nagata I, Kikuchi H, Ikada Y. 1997. Potential efficacy of basic fibroblast growth factor incorporated in biodegradable hydrogels for skull bone regeneration. J Neurosurg 86:871-875.
44. Young S, Wong M, Tabata Y, Mikos AG. 2005. Gelatin as a delivery vehicle for the controlled release of bioactive molecules. J Control Release 109:256-274.